Literature DB >> 11295097

Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women.

R E Harris1, J Beebe-Donk, K K Namboodiri.   

Abstract

Recent human epidemiologic studies suggest that non-steroidal anti-inflammatory drugs (NSAIDs) have preventive effects against cancers of the colon, breast, and prostate. Laboratory and animal studies also provide evidence of antineoplastic effects of NSAIDs against a variety of solid tumors, including skin cancer. We studied the effects of NSAIDs on malignant melanoma in women utilizing a case control experimental design involving 110 women with histologically proven malignant melanoma, and 609 female controls frequency matched to the cases on age, and place of residence. We observed a significant decrease in the relative risk (RR) of malignant melanoma with regular intake of common over the counter NSAIDs such as aspirin and ibuprofen (RR = 0.45, 95% CI = 0.22-0.92, p < 0.05). Adjustment for sun exposure did not change the magnitude of the estimate. Our results are the first to show that NSAIDs may have value in the chemoprevention of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295097     DOI: 10.3892/or.8.3.655

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation.

Authors:  Orly Ordan; Ronit Rotem; Ilona Jaspers; Eliezer Flescher
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.

Authors:  Clara Curiel-Lewandrowski; Susan M Swetter; Janine G Einspahr; Chiu-Hsieh Hsu; Ray Nagle; Paul Sagerman; Joseph Tangrea; Howard Parnes; David S Alberts; Hsiao-Hui Chow
Journal:  Cancer       Date:  2012-05-17       Impact factor: 6.860

Review 3.  Melanoma Chemoprevention: Current Status and Future Prospects.

Authors:  Gagan Chhabra; Mary Ann Ndiaye; Liz Mariely Garcia-Peterson; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2017-04-27       Impact factor: 3.421

4.  Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.

Authors:  J M Jeter; J Han; M E Martinez; D S Alberts; A A Qureshi; D Feskanich
Journal:  Cancer Causes Control       Date:  2012-07-05       Impact factor: 2.506

5.  Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.

Authors:  Debashree Basudhar; Robert C Cheng; Gaurav Bharadwaj; Lisa A Ridnour; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-02-04       Impact factor: 7.376

6.  Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative.

Authors:  Christina A Gamba; Susan M Swetter; Marcia L Stefanick; Jessica Kubo; Manisha Desai; Katrina M Spaunhurst; Animesh A Sinha; Maryam M Asgari; Susan Sturgeon; Jean Y Tang
Journal:  Cancer       Date:  2013-03-11       Impact factor: 6.860

7.  A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.

Authors:  Maryam M Asgari; Sonia S Maruti; Emily White
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

8.  Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice.

Authors:  Edoardo Zattra; Christina Coleman; Simin Arad; Elizabeth Helms; Danielle Levine; Evelyn Bord; Alexandra Guillaume; Mohamad El-Hajahmad; Edwin Zwart; Harry van Steeg; Salvador Gonzalez; Raj Kishore; David A Goukassian
Journal:  Am J Pathol       Date:  2009-10-01       Impact factor: 4.307

Review 9.  Aspirin and other NSAIDs as chemoprevention agents in melanoma.

Authors:  James R Goodman; Douglas Grossman
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-02

10.  Nonsteroidal anti-inflammatory drugs and risk of melanoma.

Authors:  Joanne M Jeter; Joseph D Bonner; Timothy M Johnson; Stephen B Gruber
Journal:  J Skin Cancer       Date:  2011-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.